Search

Your search keyword '"Glucagon -- Physiological aspects -- Analysis"' showing total 14 results
Start Over Descriptor "Glucagon -- Physiological aspects -- Analysis"
14 results on '"Glucagon -- Physiological aspects -- Analysis"'

1. New Findings in Fatty Liver Disease Described from Berlin (Alterations in Glucagon Levels and the Glucagon-to-Insulin Ratio in Response to High Dietary Fat or Protein Intake in Healthy Lean Adult Twins: A Post Hoc Analysis)

Subjects
Medical research -- Analysis -- Physiological aspects, Medicine, Experimental -- Analysis -- Physiological aspects, Dietary fat -- Physiological aspects -- Analysis, Diseases -- Analysis -- Physiological aspects, Fatty liver -- Analysis -- Physiological aspects, Insulin -- Physiological aspects -- Analysis, Physical fitness -- Physiological aspects -- Analysis, Glucagon -- Physiological aspects -- Analysis, Health
Abstract

2024 DEC 7 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on fatty liver disease have been published. According to [...]

Published
2024

3. Research Results from Scientific Institute IRCCS Eugenio Medea Update Knowledge of Affective Disorders [A systematic review of the antidepressant effects of glucagon-like peptide 1 (GLP-1) functional agonists: Further link between metabolism and ...]

Subjects
Elsevier Science B.V., Periodical publishing -- Physiological aspects -- Analysis, Glucagon -- Physiological aspects -- Analysis, Physical fitness -- Physiological aspects -- Analysis, Antidepressants -- Physiological aspects -- Analysis, Mental health -- Analysis -- Physiological aspects, Glycogen -- Analysis -- Physiological aspects, Health
Abstract

2020 JUN 20 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on Mental Health Diseases and Conditions - Affective Disorders have [...]

Published
2020

4. Studies Conducted at Scientific Institute IRCCS Eugenio Medea on Antidepressants Recently Reported [A systematic review of the antidepressant effects of glucagon-like peptide 1 (GLP-1) functional agonists: Further link between metabolism and ...]

Subjects
Elsevier Science B.V., Periodical publishing -- Physiological aspects -- Analysis, Glucagon -- Physiological aspects -- Analysis, Physical fitness -- Physiological aspects -- Analysis, Hypoglycemic agents -- Physiological aspects -- Analysis, Antidepressants -- Physiological aspects -- Analysis, Glycogen -- Physiological aspects -- Analysis, Protein kinases, Glycogen synthesis, Obesity, Peptides, Thiazolidinediones, Adenosine monophosphate, Adenosine, Editors, Polysaccharides, Health
Abstract

2019 SEP 14 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in Drugs and Therapies - Antidepressants. According to [...]

Published
2019

5. Researchers at Scientific Institute IRCCS Eugenio Medea Describe Findings in Antidepressants [A systematic review of the antidepressant effects of glucagon-like peptide 1 (GLP-1) functional agonists: Further link between metabolism and ...]

Subjects
Glucagon -- Physiological aspects -- Analysis, Physical fitness -- Physiological aspects -- Analysis, Hypoglycemic agents -- Physiological aspects -- Analysis, Antidepressants -- Physiological aspects -- Analysis, Glycogen -- Physiological aspects -- Analysis, Protein kinases, Glycogen synthesis, Obesity, Peptides, Thiazolidinediones, Adenosine monophosphate, Adenosine, Editors, Polysaccharides, Health
Abstract

2019 JUN 22 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Drugs and Therapies - Antidepressants have been published. [...]

Published
2019

6. Evaluation of Commercially Available Glucagon Receptor Antibodies and Glucagon Receptor Expression

Subjects
Diabetes therapy -- Analysis -- Physiological aspects, Viral antibodies -- Analysis -- Physiological aspects, Liver -- Analysis -- Physiological aspects, Glucose metabolism -- Analysis -- Physiological aspects, Antibodies -- Analysis -- Physiological aspects, Glucagon -- Physiological aspects -- Analysis, Health
Abstract

2022 JAN 10 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity & Diabetes Week -- According to news reporting based on a preprint abstract, our journalists obtained the [...]

Published
2022

7. New Findings on Proglucagon from Iowa State University Summarized (Characterizing effects of feed restriction and glucagon-like peptide 2 administration on biomarkers of inflammation and intestinal morphology)

Subjects
Glucagon -- Physiological aspects -- Analysis, Physical fitness -- Physiological aspects -- Analysis, Legal fees -- Physiological aspects -- Analysis, Inflammation -- Research -- Physiological aspects -- Analysis, Cattle -- Physiological aspects -- Analysis, Higher education costs -- Physiological aspects -- Analysis, Health, Iowa State University
Abstract

2017 DEC 2 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Peptide Proteins - Proglucagon have been published. According [...]

Published
2017

8. Study Data from University of Copenhagen Provide New Insights into Proinsulin (A Placebo-Controlled Study on the Effects of the Glucagon-Like Peptide-1 Mimetic, Exenatide, on Insulin Secretion, Body Composition and Adipokines in Obese, ...)

Subjects
Obesity -- Research -- Physiological aspects -- Analysis, Glucagon -- Physiological aspects -- Analysis, Physical fitness -- Physiological aspects -- Analysis, Body weight -- Physiological aspects -- Analysis, Insulin -- Research -- Physiological aspects -- Analysis, Health, University of Copenhagen
Abstract

2017 AUG 5 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in Peptide Proteins - Proinsulin. According to news [...]

Published
2017

9. A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line. (Islet Studies)

Author

Gribble, Fiona M., Williams, Leanne, Simpson, Anna K., and Reimann, Frank

Subjects
Hypoglycemic agents -- Evaluation -- Physiological aspects -- Analysis, Glucose metabolism -- Analysis -- Physiological aspects, Type 2 diabetes -- Care and treatment, Glucagon -- Physiological aspects -- Analysis, Health, Care and treatment, Evaluation, Physiological aspects, Analysis
Abstract

Glucagon-like peptide 1 (GLP-1) secretion from intestinal L-cells is triggered by luminal nutrients. We reported previously that glucose-triggered GLP-1 release from the L-cell model GLUTag involves closure of ATP-sensitive [K.sup.+] ([K.sub.ATP]) channels. We show here that GLP-1 secretion and electrical activity of GLUTag cells is triggered not only by metabolizable sugars (glucose or fructose) but also by the nonmetabolizable monosaccharide methyl-α-glucopyranoside. Responses to glucose and methyl-α-glucopyranoside were impaired by the sodium-glucose cotransporter (SGLT) inhibitor phloridzin. SLGT1 and 3 were detected in GLUTag cells by RT-PCR. Whereas fructose closed [K.sub.ATP] channels, methyl-α-glucopyranoside increased the membrane conductance and generated an inward current. Low concentrations of glucose and methyl-α-glucopyranoside also triggered small inward currents and enhanced the action potential frequency. We conclude that whereas low concentrations of metabolizable sugars trigger GLP-1 secretion via [K.sub.ATP] channel closure, SGLT substrates generate small inward currents as a result of the electrogenic action of the transporter. This transporter-associated current can trigger electrical activity and secretion when the concentration of substrate is high or when outward currents are reduced by metabolic closure of the [K.sub.ATP] channels. Electrogenic sugar entry via SGLTs provides a novel mechanism for glucose sensing by neuroendocrine cells., Glucagon-like peptide one (GLP-1) and peptide YY (PYY) are secreted from intestinal L-cells in response to dietary carbohydrate and fat (1-6). The biological activities of GLP-1 include stimulation of glucose-dependent [...]

Published
2003

10. Effect of glucagon-like peptide 1 (7.36 amide) on insulin-mediated glucose uptake in patients with type 1 diabetes. (Original Article: Pathophysiology/Complications)

Author

Meneilly, Graydon S., McIntosh, Christopher H.S., Pederson, Raymond A., Habener, Joel F., Ehlers, Mario R.W., Egan, Josephine M., and Elahi, Dariush

Subjects
Type 1 diabetes -- Physiological aspects -- Analysis, Glucose metabolism -- Analysis -- Physiological aspects, Glucagon -- Physiological aspects -- Analysis, Health, Physiological aspects, Analysis
Abstract

OBJECTIVE--To examine the insulinomimetic insulin-independent effects of glucagon-like peptide (GLP)-1 on glucose uptake in type 1 diabetic patients. RESEARCH DESIGN AND METHODS--We used the hyperinsulinemic-euglycemic clamp (480 pmol * [m.sup.-2] [...]

Published
2003

11. Research Conducted at University of Copenhagen Has Updated Our Knowledge about Insulin Resistance (Evidence of a liver-alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and ...)

Subjects
Glucagon -- Physiological aspects -- Analysis, Amino acids -- Physiological aspects -- Analysis, Diabetes therapy -- Physiological aspects -- Analysis, Insulin resistance -- Research -- Physiological aspects -- Analysis, Blood glucose -- Physiological aspects -- Analysis, Health, University of Copenhagen
Abstract

2018 MAR 9 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- A new study on Endocrine System Diseases and Conditions - Insulin Resistance is [...]

Published
2018

12. Findings from University of Calgary in the Area of Liver Diseases Reported (Glucagon-Like Peptide-2 Alters Bile Acid Metabolism in Parenteral Nutrition-Associated Liver Disease)

Subjects
Glucagon -- Physiological aspects -- Analysis, Liver diseases -- Research -- Physiological aspects -- Analysis, Medical research -- Physiological aspects -- Analysis, Nutrition -- Physiological aspects -- Analysis, Deoxycholic acid -- Physiological aspects -- Analysis, Biotechnology industry, Pharmaceuticals and cosmetics industries, University of Calgary
Abstract

2016 JAN 20 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- Current study results on Liver Diseases have been published. According to news originating from Calgary, [...]

Published
2016

13. Differences in 7B2 expression may explain variations in glucagon production and glucose tolerance

Subjects
University of Ottawa, Dextrose -- Physiological aspects -- Analysis, Diabetes -- Physiological aspects -- Analysis, Drugs -- Physiological aspects -- Analysis, Glucose -- Physiological aspects -- Analysis, Glucagon -- Physiological aspects -- Analysis, Health, Science and technology, Analysis, Physiological aspects
Abstract

Differential 7B2 pancreatic expression in C57BL/6J and C3H/HeJ mice may explain differences in glucagon production and glucose tolerance between the two genotypes. According to recent research from Canada, "C57BL/6 (B6) [...]

Published
2006

14. Differences in 7B2 expression may explain variations in glucagon production and glucose tolerance

Subjects
University of Ottawa, Dextrose -- Physiological aspects -- Analysis, Diabetes -- Physiological aspects -- Analysis, Drugs -- Physiological aspects -- Analysis, Glucose -- Physiological aspects -- Analysis, Glucagon -- Physiological aspects -- Analysis, Health, Analysis, Physiological aspects
Abstract

Differential 7B2 pancreatic expression in C57BL/6J and C3H/HeJ mice may explain differences in glucagon production and glucose tolerance between the two genotypes. According to recent research from Canada, "C57BL/6 (B6) [...]

Published
2006

Catalog

Books, media, physical & digital resources
See catalog results